Linical Co., Ltd. Logo

Linical Co., Ltd.

Global CRO providing full-service drug development support for biopharma companies.

2183 | T

Overview

Corporate Details

ISIN(s):
JP3974530002
LEI:
Country:
Japan
Address:
大阪市淀川区宮原1丁目6番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Linical Co., Ltd. is a global Contract Research Organization (CRO) that provides comprehensive, full-service drug development support to biopharmaceutical and pharmaceutical companies. The company guides clients through all phases of the clinical development journey, from early-stage research to large-scale, multinational clinical trials. Linical offers specialized expertise in complex therapeutic areas, including oncology and the central nervous system (CNS). Leveraging its global presence and deep regulatory knowledge, the firm assists partners in expediting timelines and achieving research objectives. The company is recognized for its high client retention rate and a proven track record of exceeding trial enrollment goals.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-26 09:36
Post-Annual General Meeting Information
臨時報告書
Japanese 24.4 KB
2025-06-24 09:27
Regulatory News Service
内部統制報告書-第20期(2024/04/01-2025/03/31)
Japanese 22.7 KB
2025-06-24 09:26
Regulatory News Service
確認書
Japanese 8.1 KB
2025-06-24 09:25
Annual Report
有価証券報告書-第20期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2024-11-14 08:13
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-11-14 08:09
Interim Report
半期報告書-第20期(2024/04/01-2025/03/31)
Japanese 180.6 KB
2024-06-27 09:29
Post-Annual General Meeting Information
臨時報告書
Japanese 23.6 KB
2024-06-27 09:28
Governance Information
内部統制報告書-第19期(2023/04/01-2024/03/31)
Japanese 21.7 KB
2024-06-27 09:26
Registration Form
確認書
Japanese 8.1 KB
2024-06-27 09:25
Annual Report
有価証券報告書-第19期(2023/04/01-2024/03/31)
Japanese 1.0 MB
2024-02-14 08:11
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-02-14 08:10
Quarterly Report
四半期報告書-第19期第3四半期(2023/10/01-2023/12/31)
Japanese 153.3 KB
2023-11-14 08:09
Report Publication Announcement
確認書
Japanese 8.1 KB
2023-11-14 08:08
Quarterly Report
四半期報告書-第19期第2四半期(2023/07/01-2023/09/30)
Japanese 189.9 KB
2023-08-14 09:09
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all Linical Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Linical Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Linical Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America N/A
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Ireland MURA

Talk to a Data Expert

Have a question? We'll get back to you promptly.